Washington – For the first time ever, the U.S. Food and Drug Administration has approved a marijuana-derived drug.
RELATED: Texas GOP in favor of marijuana decriminalizationNot only is the first marijuana-derived drug approved by the FDA, but the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
The component in this newly approved drug is CBD (cannabidiol), which is part of the sativa marijuana plant.
And, the FDA is committed to this kind of careful scientific research and drug development,” FDA Commissioner Scott Gottlieb, M.D, said.
The FDA is approving this new drug, despite it still being considered a Schedule 1 drug by the Drug Enforcement Agency.